Abatacept
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Abatacept is used to treat juvenile arthritis, psoriatic arthritis and rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $754 million on Abatacept across 125,000 claims for 18,000 beneficiaries.
Abatacept is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $1468.74 to $1470.24 per ML — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$1468.74 – $1470.24
per ML
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing ABATACEPT
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ORENCIA CLICKJECT 125 MG/ML | $1470.2375 per ML | -0.01% |
ORENCIA 125 MG/ML SYRINGE | $1468.7381 per ML | +0.09% |
Frequently Asked Questions
What is Abatacept used to treat?
Abatacept is used to treat juvenile arthritis, psoriatic arthritis and rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Abatacept?
In 2024, Medicare Part D spent $754 million on Abatacept across 125,000 claims for 18,000 beneficiaries.
How many Abatacept products are on the market?
The Abatacept drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Abatacept?
NADAC reference prices for Abatacept range from $1468.7381 to $1470.2375 per ML — a 0% difference between cheapest and most expensive.
Which manufacturers make Abatacept?
1 manufacturer lists Abatacept in NADAC. Ranked by number of NDCs, the largest are E.R. Squibb & Sons, L.L.C. (2).
How has the price of Abatacept changed recently?
Over the past 7 days, 1 Abatacept NDC rose and 1 fell, with a market-wide average change of +0.0%.